// App-Quantinova.ai

OC12.04 : *Applicability of morphological uterus sonographic assessment features associated with adenomyosis among experts and refinements of definitions

Researchers

Presenter

  • M. Harmsen

Principal Investigators

  • R.A. de Leeuw

  • T. van den Bosch

  • M. Dueholm

  • C. Exacoustos

  • L. Valentin

  • W.K. Hehenkamp

  • F.A. Groenman

  • C. De Bruyn

  • C. Kjaergaard

  • L. Lazzeri

  • L. Jokubkiene

  • D. Jurkovic

  • J. Naftalin

  • T. Tellum

  • D. Timmerman

  • T. Bourne

  • J.F. Huirne

Medical Centers

  • Obstetrics and Gynecology, University Hospital Leuven, Leuven, Belgium

  • KU Leuven, Leuven, Belgium

  • Gynecology, Oslo University Hospital, Ullevål, Oslo, Norway

  • Department of Obstetrics and Gynecology, Skåne University Hospital, Malmö, Sweden

  • Department of Obstetrics and Gynecology, Aarhus University Hospital, Aarhus, Denmark

  • Karolinska University Hospital, Stockholm, Sweden

  • Gynecology Diagnostic and Outpatient Treatment Unit, University College Hospital, London, United Kingdom

  • Department of Obstetrics and Gynecology, Queen Charlotte's and Chelsea Hospital, Imperial College, London, United Kingdom

  • Department of Molecular and Developmental Medicine, Obstetrics and Gynecological Clinic, University of Siena, Siena, Italy

  • Obstetrics and Gynecology, Amsterdam University Medical Centre, Location AMC and VUMC, Amsterdam, Netherlands

  • Department of Biomedicine and Prevention, Obstetrics and Gynecology Clinic, Università degli Studi di Roma “Tor Vergata”, Rome, Italy

  • University Hospital Antwerp, Edegem, Antwerp, Belgium

Locations

  • Belgium

  • Norway

  • Sweden

  • Denmark

  • United Kingdom

  • Italy

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Obstetrics/Gynecology

Disease

  • Adenomyosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A